NAAF is pleased to announce that Zura Bio has joined the Industry Partner Program at the Bronze membership level. Zura…
Media reports of two newly approved drugs for treating alopecia areata brought good news to many people living with the…
Today, the U.S. Food and Drug Administration (FDA) approved LITFULO™ for severe alopecia areata, marking the second FDA-approved treatment for…
Does alopecia areata (AA) affect all races and ethnic groups equally? If yes, why is this important? Knowing AA prevalence…
Results from a clinical trial for a new treatment for alopecia areata were published in the medical journal The Lancet…
As we come to the close of 2022, we look upon these past 12 months as among the most pivotal…
When you participate in a survey that comes to you in a NAAF email, what happens to your responses? For…
Today we received the welcome news that the U.S. Food and Drug Administration (FDA) accepted for filing the New Drug…
Today, history was made as the U.S. Food and Drug Administration (FDA) approved Olumiant™ for alopecia areata, marking the first…
